A Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Tocilizumab, An Interleukin-6 Receptor Antibody, For Residual Symptoms in Schizophrenia

Authors: Ragy R. Girgis, Adam Ciarleglio, Tse Choo, Gregory Haynes, Joan M. Bathon, Serge Cremers, Joshua T. Kantrowitz, Jeffrey A. Lieberman, Alan S. Brown - Neuropsychopharmacology 2017 cited by 126